Covid Inquiry: Abuse of experts must stop, says Whitty
Sir Chris laments treatment as he gives evidence to Covid Inquiry on pandemic preparedness.
Similar Posts
J&J to acquire Ambrx Biopharma, a cancer drug developer, for $2B
An entry sign to the Johnson & Johnson campus shows their logo in Irvine, California on August 28, 2019. Mark Ralston | AFP | Getty Images Johnson & Johnson on Monday said it will pay $2 billion in cash to acquire Ambrx Biopharma, a drugmaker specializing in one of the hottest areas of cancer treatment….
Ohio boy’s rare and fatal disease, prostate cancer myths, and psychedelics for PTSD
Grayson Naff, 8, pictured at right and with his family, was diagnosed with Batten disease in spring 2023. “I really don’t have words for it,” said mom Emily Blackburn to Fox News Digital. (Emily Blackburn) ‘GUT-WRENCHING’ – Emily Blackburn is pushing for research and funds to help her 8-year-old son, Grayson Naff, who has a…
Daylesford Organic recall biscuits over moth larvae
Food Standards Agency’s Head of Incidents, Rajwinder Ubhi said: “Daylesford Organic Rye, Spelt & Raisin Crispbreads and Savoury Biscuit Selection have been recalled by the business because the Crispbreads have been contaminated by moth larvae, making the products unsafe to eat.
Cancer causes: These 10 hidden carcinogens can raise the risk, according to an oncology expert
Read this article for free! Plus get unlimited access to thousands of articles, videos and more with your free account! Please enter a valid email address. By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the content, check your…
Bowels, bladders and sex: Rediscovering life after mountain crash
Extreme sportsman Niall McCann talks frankly about life after crashing into a mountain at 50mph.
Moderna Covid vaccine sales plunge in 2023, but meet company forecast
Nikos Pekiaridis | Lightrocket | Getty Images Moderna on Monday said its Covid vaccine sales plunged by about two-thirds in 2023 to $6.7 billion, as fewer people rolled up their sleeves for an updated version of the jab. The revenue from the shots met Moderna’s forecast for the year, even as sales plummeted from the…